SYNERKINE PHARMA
Synerkine Pharma focuses on developing novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain. The company's protein targets common regulatory mechanisms in different types of chronic pain and has unique properties, enabling patients to effectively reduce pain in multiple pre-clinical models.
SYNERKINE PHARMA
Industry:
Biotechnology Health Care
Founded:
2009-01-01
Address:
Utrecht, Utrecht, The Netherlands
Country:
The Netherlands
Website Url:
http://www.synerkinepharma.com
Total Employee:
1+
Status:
Active
Total Funding:
6.8 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Microsoft Exchange Online Organization Schema Office 365 Mail Typekit
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Utrecht Holdings
Utrecht Holdings investment in Series A - Synerkine Pharma
Thuja Capital
Thuja Capital investment in Series A - Synerkine Pharma
Flerie Invest
Flerie Invest investment in Series A - Synerkine Pharma
Thuja Capital
Thuja Capital investment in Series A - Synerkine Pharma
Official Site Inspections
http://www.synerkinepharma.com
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
